What Is Ridgetech, Inc. (RDGT) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Ridgetech, Inc.'s intrinsic value is estimated at $2.66, suggesting a +65.4% average upside from the current price of $1.61. While 5 models see room for appreciation, model agreement is not unanimous as 4 models flag potential overvaluation. Model dispersion is worth noting: EPV targets $6.29 (+290.7%), versus Bayesian DCF at $0.37 (-77.2%). This +367.9% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About RDGT?
9 of 13 models are currently active for RDGT. Of these, 5 models suggest upside while 4 models suggest overvaluation. The Bayesian DCF estimates RDGT's intrinsic value at $0.37, implying -77.2% downside from the current price. See which stocks rank higher →
How Does RDGT Rank in Retail-Drug Stores and Proprietary Stores?
Among 5 Retail-Drug Stores and Proprietary Stores stocks, RDGT ranks #5 by Quality of Company score. CirclFi's QOC score of 2.5/10 evaluates 32 fundamental signals. A score of 2.5 signals below-average fundamentals.
As a biopharma enterprise, Ridgetech, Inc. operates in a sector where biosimilar competition timeline is a critical driver of valuation. Investors evaluating RDGT should weigh these sector-specific dynamics alongside our model-derived fair values.
Is RDGT a Value Trap?
The Value Trap algorithm is not active for RDGT. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
9 of 13 models are active for Ridgetech, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Ridgetech, Inc.'s fundamental quality profile registers 2.5/10. This concerning score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +367.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every RDGT valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across RDGT's 9 active models, average confidence is 19%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →